Does hydroxychloroquine combat COVID-19? A timeline of evidence

doi:10.1016/j.jaad.2020.04.031

. 2020 Jul;83(1):e33-e34.

doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10.

Does hydroxychloroquine combat COVID-19? A timeline of evidence

Erisa Alia¹, Jane M Grant-Kels²

Affiliations

¹ Dermatology Department, University of Connecticut, Farmington, Connecticut.
² Dermatology Department, University of Connecticut, Farmington, Connecticut. Electronic address: grant@uchc.edu.

PMID: 32283236
PMCID: PMC7151328
DOI: 10.1016/j.jaad.2020.04.031

Does hydroxychloroquine combat COVID-19? A timeline of evidence

Erisa Alia et al. J Am Acad Dermatol. 2020 Jul.

. 2020 Jul;83(1):e33-e34.

doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10.

Authors

Erisa Alia¹, Jane M Grant-Kels²

Affiliations

¹ Dermatology Department, University of Connecticut, Farmington, Connecticut.
² Dermatology Department, University of Connecticut, Farmington, Connecticut. Electronic address: grant@uchc.edu.

PMID: 32283236
PMCID: PMC7151328
DOI: 10.1016/j.jaad.2020.04.031

No abstract available

PubMed Disclaimer

Comment in

Risks of hydroxychloroquine use for COVID-19 prophylaxis.
Sachdeva M, Shah M, Ziv M, Leshem E, Dodiuk-Gad RP. Sachdeva M, et al. J Am Acad Dermatol. 2020 Jul;83(1):e73-e74. doi: 10.1016/j.jaad.2020.04.111. Epub 2020 Apr 26. J Am Acad Dermatol. 2020. PMID: 32348818 Free PMC article. No abstract available.

Cited by

Acute generalized exanthematous pustulosis due to hydroxichloroquine.
Odorici G, Schenetti C, Pacetti L, Schettini N, Gaban A, Mantovani L. Odorici G, et al. Dermatol Ther. 2022 Jul;35(7):e15520. doi: 10.1111/dth.15520. Epub 2022 Apr 23. Dermatol Ther. 2022. PMID: 35434875 Free PMC article. No abstract available.
Efficacy of early use of remdesivir: a systematic review of subgroup analysis.
Gil-Sierra MD, Briceño-Casado MP, Alegre-Del Rey EJ, Sánchez-Hidalgo M. Gil-Sierra MD, et al. Rev Esp Quimioter. 2022 Jun;35(3):249-259. doi: 10.37201/req/154.2021. Epub 2022 Mar 17. Rev Esp Quimioter. 2022. PMID: 35294145 Free PMC article.
Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis.
Deng J, Zhou F, Heybati K, Ali S, Zuo QK, Hou W, Dhivagaran T, Ramaraju HB, Chang O, Wong CY, Silver Z. Deng J, et al. Future Virol. 2021 Nov:10.2217/fvl-2021-0119. doi: 10.2217/fvl-2021-0119. Epub 2021 Dec 3. Future Virol. 2021. PMID: 34887938 Free PMC article. Review.
Hydroxychloroquine serum concentration in coronavirus disease 2019 (COVID-19) patients: a retrospective study.
Zohra SF, Nassima L. Zohra SF, et al. Forensic Sci Res. 2021 Aug 19;6(3):215-217. doi: 10.1080/20961790.2021.1936896. eCollection 2021. Forensic Sci Res. 2021. PMID: 34868713 Free PMC article.
Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
Chen Z, Liu A, Cheng Y, Wang X, Xu X, Huang J, Ma Y, Gao M, Huang C. Chen Z, et al. BMC Infect Dis. 2021 Aug 12;21(1):805. doi: 10.1186/s12879-021-06477-x. BMC Infect Dis. 2021. PMID: 34384388 Free PMC article.

See all "Cited by" articles

References

1. Wang M., Cao R., Zhang L., et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. - PMC - PubMed
1. Audio transcript of the news briefing held by the State Council of China on February 17, 2020 [in Chinese]. The National Health Commission of the People's Republic of China. http://www.nhc.gov.cn/xcs/yqfkdt/202002/f12a62d10c2a4 8c6895cedf2faea6e1... Available at:
1. Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73. - PubMed
1. Chinese Clinical Trial Registry (CHICTR). Available at: http://www.chictr.org.cn/searchprojen.aspx?title=hydroxychloroquine&offi.... Accessed April 3, 2020.
1. Biot C., Daher W., Chavain N., et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006;49(9):2845–2849. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

[1] Wang M., Cao R., Zhang L., et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. - PMC - PubMed

[2] Wang M., Cao R., Zhang L., et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. - PMC - PubMed

[3] Audio transcript of the news briefing held by the State Council of China on February 17, 2020 [in Chinese]. The National Health Commission of the People's Republic of China. http://www.nhc.gov.cn/xcs/yqfkdt/202002/f12a62d10c2a4 8c6895cedf2faea6e1... Available at:

[4] Audio transcript of the news briefing held by the State Council of China on February 17, 2020 [in Chinese]. The National Health Commission of the People's Republic of China. http://www.nhc.gov.cn/xcs/yqfkdt/202002/f12a62d10c2a4 8c6895cedf2faea6e1... Available at:

[5] Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73. - PubMed

[6] Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73. - PubMed

[7] Chinese Clinical Trial Registry (CHICTR). Available at: http://www.chictr.org.cn/searchprojen.aspx?title=hydroxychloroquine&offi.... Accessed April 3, 2020.

[8] Chinese Clinical Trial Registry (CHICTR). Available at: http://www.chictr.org.cn/searchprojen.aspx?title=hydroxychloroquine&offi.... Accessed April 3, 2020.

[9] Biot C., Daher W., Chavain N., et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006;49(9):2845–2849. - PubMed

[10] Biot C., Daher W., Chavain N., et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006;49(9):2845–2849. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Does hydroxychloroquine combat COVID-19? A timeline of evidence

Affiliations

Does hydroxychloroquine combat COVID-19? A timeline of evidence

Authors

Affiliations

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources